Table 4.
Average MASQ Total Score by Group
| Variable by Time Point | Control* |
Chemotherapy |
No Chemotherapy |
|||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Baseline | 85.5 | 17.8 | 83.9 | 24.3 | 86.8 | 20.8 |
| 1 month after treatment | 88.7 | 20.6 | 98.8 | 25.3 | 91.8 | 24.2 |
| 6 months after treatment | 86.2 | 21.3 | 96.2 | 25.2 | 92.9 | 23.4 |
| 18 months after treatment | 83.1 | 20.6 | 99.7 | 26.2 | 90.8 | 26.3 |
Abbreviations: MASQ, Multiple Ability Self-Report Questionnaire; SD, standard deviation.
*
Sample size for the control group was 44 at baseline, and 43, 42 and 39 at 1, 6, and 18 months after treatment, respectively. For the chemotherapy group, the sample sizes were 60, 55, 49 and 46, respectively. For the no chemotherapy group, the sample sizes were 72, 68, 67 and 64, respectively.